Congratulations to Andrew King who successfully defended his Master's thesis research on December 5, 2016. Andrew's project was entitled "Evaluating G-protein subunit Gamma-t;s effect on cell migration in a model system of Kallmann Syndrome using CRISPR/CAS9. Kallman Syndrome is a rare genetic disorder characterized by an absent or impaired sense of smell and a failure to initiate or complete puberty due to a deficiency of gonadotropin releasing hormone. CRISPR/CAS9 is a new tool for genome editing. Dr.William Schwindinger is Andrew's thesis advisor. Serving on his thesis committee were Drs. Hansen and Brubaker. Andy has presented portions of this work at the Tri-Beta Northeast District 2 Convention and the College of Science and Technology Research Day.